• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.96% Nasdaq Up0.91%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    20.30 Up 0.63(3.20%) 1:32PM EDT - Nasdaq Real Time Price
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 109,300   108,735   96,152   123,884  
    Cost of Revenue23,826  25,447  22,349  19,679  
    Gross Profit 85,474   83,288   73,803   104,205  
    Operating Expenses
    Research Development14,229  7,897  19,809  8,184  
    Selling General and Administrative63,175  50,255  46,141  31,801  
    Non Recurring622  2,463  9,238  3,096  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 7,448   22,673   (1,385) 61,124  
    Income from Continuing Operations
    Total Other Income/Expenses Net928  537  (19,107)374  
    Earnings Before Interest And Taxes8,376  23,210  (20,492)61,498  
    Interest Expense18,443  18,457  14,222  10,205  
    Income Before Tax(10,067)4,753  (34,714)51,293  
    Income Tax Expense(2,540)(2,448)(14,130)18,035  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(7,527)7,201  (20,584)33,258  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (7,527) 7,201   (20,584) 33,258  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (7,527) 7,201   (20,584) 33,258  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.